โ† Back to Blog

Specification-Driven Raw Material Acceptance Criteria for Gummy Supplement Facilities

๐ŸŽฏ Free GMP Consultation  ยท  Book Now โ†’

Why Acceptance Criteria Are Not the Same as a Testing Program

Many gummy supplement facilities treat raw material testing and acceptance criteria as the same thing. They are not. A testing program tells you what to measure. Acceptance criteria tell you what numbers are acceptable โ€” and critically, what happens when a result falls outside those numbers. Under 21 CFR Part 111, specifically Sections 111.70 and 111.75, you are required to establish component specifications and to test or examine components against those specifications before use in production. Having a COA from your supplier and a standing order to send it to QA is not a specification-driven acceptance program. It is a documentation habit, and FDA investigators know the difference.

For gummy manufacturers, the stakes around acceptance criteria are higher than in many other supplement formats. Gelatin bloom strength, pectin methoxylation degree, sugar particle size, moisture content, water activity of incoming powders, and active ingredient potency all interact during cooking, depositing, and drying in ways that cascade through the entire batch. A gelatin that barely meets a vague "acceptable" qualifier on your COA review checklist can perform entirely differently at your cook temperature than a lot that was clearly within a tighter bloom range. If your acceptance criteria cannot differentiate between those two lots, your specification is not doing its job.

The practical starting point is separating your component list into functional categories and assigning meaningful, measurable criteria to each one โ€” not just "meets COA" or "visually acceptable." Every critical raw material in a gummy formula should have a written specification that includes identity, purity, physical attributes, and where relevant, functional performance parameters. That specification should live in your approved supplier documentation, be referenced in your master manufacturing record, and be tested against at incoming receipt before the lot is released from quarantine.

Building Acceptance Criteria for Gummy-Specific Base Ingredients

The base ingredients in a gummy โ€” gelatin or pectin, sweeteners, humectants, and water โ€” define the physical structure of the product. Their acceptance criteria need to reflect both the chemical specifications from your supplier and the functional requirements of your process. This is where most generic GMP templates completely fail gummy manufacturers: a template written for capsule or tablet manufacturing has no concept of bloom strength, gel temperature, or setting time, so it provides no framework for writing criteria that actually protect your process.

Gelatin

For gelatin, your acceptance criteria should address bloom strength (typically expressed in grams, with a range appropriate for your formula and cook temperature), viscosity, ash content, heavy metals, microbiological limits, and moisture. Bloom strength is the single most important functional parameter for gelatin-based gummies. A lot that arrives at 180 bloom when your formula was developed and validated at 220 bloom will produce a softer, potentially unstable gummy that may fail texture testing, packaging integrity checks, or shelf-life benchmarks. Your acceptance criteria must specify a minimum bloom value โ€” not just reference the supplier's nominal grade โ€” and your incoming testing program must verify it, because bloom values on a COA can drift from lot to lot even within a declared grade.

Pectin

For pectin-based gummies, degree of esterification (DE) is the equivalent functional parameter. High-methoxyl pectins and low-methoxyl pectins gel through different mechanisms and require different pH and soluble solids conditions to set properly. Your acceptance criteria should specify the DE range appropriate for your formula, as well as pH of a standard solution, viscosity, ash, and heavy metals. Receiving a low-methoxyl pectin when your formula expects high-methoxyl will not just produce a softer gummy โ€” it may not set at all under your standard process conditions, because the gelling mechanism is fundamentally different.

Sweeteners and Humectants

For sugars, glucose syrups, and humectants like glycerin and sorbitol, acceptance criteria should cover identity confirmation (particularly critical if you are sourcing from multiple suppliers or switching suppliers), purity, moisture, specific gravity or Brix where relevant, and microbiological limits. Glucose syrup DE value matters for gummy texture and water activity โ€” a high-DE syrup will behave differently in your mogul or depositing system than a low-DE syrup, affecting both process viscosity and the final product's moisture equilibrium during shelf life.

Acceptance Criteria for Active Ingredients and Botanical Extracts

Active ingredients โ€” vitamins, minerals, botanical extracts, amino acids, and specialty ingredients like melatonin or elderberry โ€” require a separate tier of acceptance criteria that addresses both identity and potency. Under 21 CFR Part 111.75, you must verify the identity of each dietary ingredient component before use, and you must have at least one test or examination to verify purity, strength, and composition. For components that are the basis of a label claim, potency verification at incoming receipt is not optional โ€” it is a regulatory baseline.

Potency acceptance criteria should be set based on your formula's overage assumptions and your target finished product specification. If your formula includes a five percent overage to account for processing losses and shelf-life degradation, your incoming acceptance criterion for that active should reflect the potency range needed to achieve the target finished product result โ€” not simply "meets label claim" or "within supplier tolerance." A vitamin C incoming lot that tests at the low end of your supplier's declared range, combined with higher-than-expected cooking losses, can result in a finished gummy that fails potency at end of shelf life even though every individual step appeared compliant.

For botanical extracts, your acceptance criteria should address standardized marker compound concentration, heavy metals (especially arsenic, cadmium, lead, and mercury under USP <2232>), pesticide residues, solvent residues if applicable, and microbiological limits. The certificate of analysis from a botanical extract supplier may list an impressive array of parameters, but your acceptance criterion must specify the minimum and maximum values your QC team will accept โ€” not simply require that a COA exists. Criteria for botanical identity should reference a recognized method, such as HPTLC or HPLC fingerprinting, particularly for ingredients where adulteration is a known supply chain risk, such as elderberry, ashwagandha, or turmeric.

Water Activity as an Acceptance Criterion for Incoming Powders

Water activity is well understood as a finished product control in gummy manufacturing โ€” most facilities track it as part of release testing because water activity above 0.65 is associated with microbial growth risk and water activity above 0.75 can accelerate degradation in moisture-sensitive actives. What fewer facilities build into their incoming acceptance programs is water activity measurement for incoming powders, particularly botanical extracts, hydrophilic vitamins, and hygroscopic excipients like citric acid or ascorbic acid.

An incoming powder with elevated water activity โ€” whether from improper storage during transit, humidity exposure at a repackager, or a processing issue at the supplier โ€” can introduce moisture into your formula in a way that disrupts your cook, your depositing viscosity, or your final product's water activity equilibrium. If your formula is tightly dialed to achieve a finished water activity of 0.55 to 0.60, and you are adding a botanical powder that arrived at water activity 0.72 instead of the expected 0.45, your finished product may test outside your specification without any obvious process failure to explain it. Building incoming water activity limits into your acceptance criteria for hygroscopic or moisture-sensitive ingredients closes this gap before it reaches production.

Practically, water activity measurement is fast, inexpensive, and requires only a benchtop meter. Including it as an incoming test for flagged ingredient categories โ€” and documenting the acceptance limit in your component specification โ€” adds meaningful protection to your process with minimal laboratory burden. NSF GMP auditors and FDA investigators reviewing your incoming testing program will recognize water activity measurement for incoming powders as evidence of a facility that understands gummy-specific risk, not just generic supplement GMP compliance.

Documenting Acceptance Criteria So They Survive an Audit

Well-designed acceptance criteria are only as strong as the documentation that supports them. Under 21 CFR Part 111, your component specifications must be in writing, and your records must demonstrate that incoming components were tested or examined against those specifications before release. That documentation chain needs to connect your approved supplier file, your component specification, your incoming test results, and your release or rejection decision in a way that an FDA investigator or NSF auditor can follow without your QA manager narrating it for them.

Each component specification should be a controlled document with a version number, effective date, approval signature, and clear listing of every acceptance criterion for that ingredient. When an incoming lot is tested, the test results should reference the lot number, the specification document, and the individual acceptance criteria โ€” not just report a number without context. A COA from your supplier should be attached to the lot record, but your internal test results โ€” generated by your laboratory or your qualified third-party contract laboratory โ€” should be documented separately and clearly identified as your verification, not a re-statement of the supplier's data.

Rejection and disposition procedures need to be equally explicit. If an incoming lot fails a criterion, your documentation must capture what the out-of-specification result was, who made the disposition decision, whether an investigation was opened, and what happened to the rejected material. Facilities that approve borderline lots without a documented rationale, or that lack a clear chain from failing result to disposition decision, consistently receive 21 CFR Part 111 observations during FDA inspections. For gummy manufacturers pursuing NSF GMP certification or building documentation packages for Amazon supplement compliance reviews, a clean, traceable acceptance criteria documentation system is foundational โ€” not aspirational.

If your current incoming testing program produces results but those results are not being evaluated against written, numerical acceptance criteria for every critical parameter, the first step is not adding more tests. It is writing tighter specifications so that the tests you are already running have a defined pass-fail threshold. That shift โ€” from testing as a documentation habit to testing as a specification-driven release gate โ€” is what separates a GMP-compliant incoming program from one that looks compliant on paper but fails to protect your batches, your customers, or your facility's regulatory standing.

Ready to Get GMP Certified?

Book a free 30-minute compliance consultation with a GummyGMP expert. We'll map out exactly what your facility needs to reach certification.

Book Your Free Call โ†’